C
Chris D. Metcalfe
Researcher at Trent University
Publications - 210
Citations - 13864
Chris D. Metcalfe is an academic researcher from Trent University. The author has contributed to research in topics: Japanese Medaka & Environmental impact of pharmaceuticals and personal care products. The author has an hindex of 61, co-authored 210 publications receiving 12672 citations. Previous affiliations of Chris D. Metcalfe include United Nations University.
Papers
More filters
Journal ArticleDOI
Fish micronuclei for assessing genotoxicity in water
Kabil Al-Sabti,Chris D. Metcalfe +1 more
TL;DR: The literature on the clastogenic effects of chemical and physical agents on fish cells, with emphasis on the induction of micronuclei in teleosts is reviewed, directing laboratories in the development of fish genotoxicity assays for water quality monitoring.
Journal ArticleDOI
Estrogenic potency of chemicals detected in sewage treatment plant effluents as determined by in vivo assays with Japanese medaka (Oryzias latipes).
Chris D. Metcalfe,Tracy L. Metcalfe,Yiannis Kiparissis,Brenda G. Koenig,Colin Khan,Richard J. Hughes,Timothy R. Croley,Raymond E. March,Thomas L. Potter +8 more
TL;DR: Results with the medaka assay were consistent with estrogenic responses in the yeast estrogen screening assay, indicating that concentrations of estrogen hormones detected in the final effluents of sewage treatment plants are generally greater than the lowest‐observed‐effect levels for alterations to gonadal development in medaka.
Journal ArticleDOI
Potential scenarios for nanomaterial release and subsequent alteration in the environment
Bernd Nowack,James F. Ranville,Stephen A. Diamond,Julian A. Gallego-Urrea,Chris D. Metcalfe,Jérôme Rose,Nina Horne,Albert A. Koelmans,Stephen J. Klaine +8 more
TL;DR: It is not possible to assess the risks associated with the use of ENM by investigating only the pristine form of the ENM, without considering alterations and transformation processes, and a more definitive classification scheme for ENM should be adopted.
Journal ArticleDOI
Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants.
TL;DR: The rates of elimination of ibuprofen and naproxen appeared to be elevated in STPs with hydraulic retention times for sewage greater than 12 h, and the widespread occurrence of carbamazepine at concentrations as high as 2.3 microg/L may be explained by use of this drug for other therapeutic purposes besides treatment of epilepsy and its resistance to elimination inSTPs.
Journal ArticleDOI
Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant.
TL;DR: The results showed that 29% of the carbamazepine was removed from the aqueous phase during treatment in the WWTP, while the metabolites were not effectively removed, which appeared to be due primarily to degradation.